U.S. Markets closed

A Big Outside Day and Lower Close on Sage Therapeutics Looks Bearish to Me

Bruce Kamich

, which just received FDA approval for Zulresso, the first treatment for postpartum depression. Dr. Jonas said that postpartum depression is the most common complication for women after childbirth, and suicide remains a leading cause of death among adults overall.